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This investigation was carried out to evaluate the safety of an aqueous extract of Morinda citrifolia 
leaves (AEMC) by determining its potential toxicity after acute administration (5 g/kg) in rodents and 
cytotoxic studies. General behavior adverse effects and mortality were determined for up to 14 days. 
Biochemical and hematological parameters were determined after 14 days. Cytotoxic effects of the 
AEMC were determined by spectrophotometric 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) assay (at concentration of 0.05 to 25 mg/ml). The results showed that in the acute 
study in rats, the AEMC did not cause general behavior adverse effects and mortality. Also, AEMC 
did not show any cytotoxic effect at 0.05 to 12.5 mg/ml, only at 25 mg/ml. The AEMC does not appear 
to have significant toxicity.  
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INTRODUCTION 
 
In recent years, there has been a growing interest in 
identifying naturally occurring minor dietary constituents 
against the development of several diseases. Plant 
derived foodstuffs, particularly fruits and vegetables are 
generally considered to be highly beneficial components 
of the human diet (Calixto and Siqueira, 2008; Yunes, 
2001). 
Empirical use of medicine derived from plants has been 
widely disseminated since ancient times to treat a wide 
range of diseases. In the last decades, the interest in 
alternative therapies has raised markedly in a worldwide 
shape. The occurrence of side effects from plant derived 
medicines,   when  used in  an  appropriate  manner,  are 
relatively  less  frequent   when   compared   to   synthetic  
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drugs. However, experimental data have shown that they 
are not absent of adverse reactions even in these cases, 
which makes toxicological controlled studies necessary to 
assess their safety (Calixto, 2000). Morinda citrifolia L. 
(Rubiaceae), the ‘‘noni’’, has been used in traditional 
Polynesian medicine for over 2000 years. Chi-Tang Ho 
and researchers have successfully identified several new 
flavonol glycosides and iridoid glycoside from the ‘‘noni’’ 
leaves (Wang et al., 2002). A number of major 
components have been identified in the ‘‘noni’’ plant such 
as scopoletin, octoanoic acid, potassium, vitamin C, 
terpenoids,  alkaloids,  anthraquinones, β-sitosterol, 
carotene, vitamin A, flavone glycosides, linoleic acid, 
Alizarin, amino acids, acubin, L-asperuloside, caproic 
acid, caprylic acid, ursolic acid, rutin and a putative 
proxeronine (Wang et al., 2002; Simonsen, 1920; 
Heinicke, 1985). 
The leaves and especially the fruit are consumed in 
different  forms  by  various  communities  throughout  the 
  
 
 
world. The fruit is claimed to prevent and cure several 
diseases. It is primarily used to stimulate the immune 
system and thus to fight bacterial, viral, parasitic and 
fungal infections. It is also used to prevent the formation 
and proliferation of tumors, including malignant ones 
(Chan-Blanco et al., 2006; Wang et al., 2002). Despite of 
this reputation and the market around the ‘‘noni’’, 
consumption of this fruit is currently high, not only in the 
producing countries, but also in the United States, Japan 
and Europe (Chan-Blanco et al., 2006).  
However, no scientific information is available about the 
pharmacological, biological and toxicological effects of 
leaves of M. citrifolia. Thus, the overall objective of the 
present work was to evaluate the effects of the aqueous 
extract of M. citrifolia (AEMC) leaves on the cytotoxicity, 
oxidative damage and acute toxicity. 
 
 
MATERIALS AND METHODS 
 
Samples 
 
M. citrifolia leaves were collected in São Cristóvão, Sergipe, Brazil 
(10°18'20.7"(S); 36°39'7.2"(W)). Herbarium voucher specimens 
(registry number 13503) were prepared and deposited at the 
Department of Biology of the Federal University of Sergipe. The 
AEMC was prepared by boiling in distilled water (7.5%; w/v) for 15 
min, the solvent evaporated off under reduced pressure and 
lyophilized. 
 
 
In vitro experiments 
 
MTT assay 
 
L929 mice fibroblast from the Rio de Janeiro Cell Bank, University 
of Rio de Janeiro, Rio de Janeiro, Brazil, were routinely grown in 
150 cm2 tissue culture flasks in DMEM supplemented with 1% (v/v) 
of an antibiotic solution containing 5 mg of penicillin, 5 mg of 
streptomycin and 10 mg of neomycin per ml, and 7.5% or 10.0% 
(v/v) heat-inactivated Fetal Bovine Serum at 37°C under 5% CO2. 
The sensitivity of cells to AEMC was determined by a standard 
spectrophotometric 3-(4,5-dimethylthiazole-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay (Mossmann, 1983). Cells 
were seeded at a density of 105 cells/well into 96 well plates and 
incubated for 24 h at 37°C in atmosphere of 95% air and 5% CO2. 
Then, 20 µl of AEMC, at different concentrations in phosphate 
buffer saline (PBS) was added to the culture plates for 24 h. After 
treatment, cells were rinsed once with PBS and serum-free culture 
medium without phenol red was replaced in all wells. Cells were 
then incubated for 4 h with MTT solution (5 mg/ml).  
The yellow tetrazolium salt was metabolized by viable cells to 
form purple crystals of formazan. The crystals were solubilized 
overnight (12 h) in a mixture consisting of 20% sodium dodecyl 
sulfate (SDS) in HCl (0.01 M). The product was quantified 
spectrophotometrically by measuring absorbance at 570 nm using a 
microplate reader (µQuantTM, BioTek Instruments Inc., USA). The 
cellular viability was expressed as the percentage of viable cells 
compared to the control group. 
 
 
In vivo experiments 
 
Male and female wistar rats (150 to 200 g) were obtained  from  the 
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Federal University of Sergipe (Sergipe, Brazil). The animals were 
kept under conventional conditions of temperature (20 ± 2°C) and 
lodged in polypropylene cages, with food and water ad libitum. 
Experimental protocols were approved by the Committee on Animal 
Research at the Federal University of Sergipe (CEPA/UFS 
23/2010).  
 
 
Acute toxicity study 
 
Toxicological assays were performed with the animals distributed in 
4 groups of 6 animals (experimental and control groups of male and 
female rats). The animals were treated by oral administration 
(gavage), adopting 5 g/kg as the maximum dose to be used (Lorke, 
1983).  
AEMC was dissolved in saline (vehicle) and it was given to the 
experimental groups, whereas only saline was given to the control 
groups. Specific behaviors (piloerection, palpebralptosis, abdominal 
contortions, locomotion, hypothermia, muscular tonus, trembling, 
forepaws paralysis, sedation, ambulation reduction, response to 
touch, analgesia, and defecation) were observed and graded 
according to Almeida et al. (1999) for 0, 15 and 30 min and 1, 2, 3 
and 4 h after gavage. 
Thus, behavioral changes and general appearances were 
observed once a day, as well as body weights, food and water 
consumption. Also, the animals were monitored daily for 14 days to 
verify lethality. 
A necropsy was performed at the end of the experiment. Blood 
samples were collected from the abdominal aorta under light ether 
anesthesia. Subsequently, a detailed study of the gross and 
microscopic features of the internal organs, as well as a 
hematological and biochemical analyses of blood, were carried out. 
The position, shape, size, texture, consistency and color of the 
internal organs (lungs, heart, stomach, liver, brain and kidneys) 
were macroscopically observed, looking for any signs of gross 
changes. These organs were then weighed to determine relative 
organ weights and preserved in 10% phosphate buffered formalin 
solution and the organs were routinely processed for embedding in 
paraffin, sectioned and stained with hematoxylin and eosin for 
subsequent histological procedures. 
 
 
Hematological analysis  
 
Blood samples were collected into EDTA tubes. Measurements of 
erythrocyte, hemoglobin, hematocrit, leukocyte, neutrophil, 
lymphocyte, eosinophil, monocyte, basophil, atypical lymphocyte 
and platelets were determined by using Pentra-120 (ABX-HORIBA) 
automated equipment according to the method described by Morris 
and Davey (1999). 
 
 
Biochemical parameters 
 
The serum was separated from the non-heparinized blood and 
assayed for serum urea, creatinine, total protein, globulin, albumin, 
aspartate amino transferase (AST), alanine amino transferase 
(ALT), Gamma-glutamyl transferase (GGT), total billirubin (TBil), 
direct bilirubin (DBil), alkaline phosphatase (ALP), calcium, sodium, 
potassium and uric acid. Biochemical parameters were determined 
by using dimension RXL (DADE BEHRING) automated equipment. 
 
 
Tissue analysis 
 
Formalin-fixed samples of the internal organs were dehydrated, 
diafanized and embedded in paraffin according to routine protocol 
of histological  procedures.  Five  micrometer  thin  sections  of   the  
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Figure 1. Cytotoxic effect of the AEMC in L929 cell line pretreated with the extracts at 
concentrations (0.05 to 12.8 mg/ml) for 24 h. Each value represents the mean ± SD. 
 
 
 
paraffin-embedded tissues were obtained and stained by means of 
hematoxilin eosin histochemical method. Morphological analysis of 
the histological sections was performed by light microscopy 
following a closed numerical protocol in such a manner as the 
pathologist was not aware of what group was being evaluated until 
the end of the experiment. 
 
 
Ex vivo experiments 
 
Oxidative damage 
 
About 1 g of liver was homogenized in 2 ml of buffer solution of 
PBS 1:2 (w/v; 1 g tissue with 2 ml PBS, pH 7.4). Homogenates 
were centrifuged at 10,000 × g for 15 min at 4ºC, and the resultant 
supernatant was used for the determination of thiobarbituric acid 
reactive substances (TBARS).  
The lipid peroxidation level in liver homogenate was measured as 
malondialdehyde (MDA) according to Buege and Aust (1984). 
Thus, 125 µl of supernatant were homogenized by sonication with 
50 µl of PBS, 125 µl of trichloro acetic acid – butyl hydroxyl toluene 
(TCA–BHT) in order to precipitate proteins, and then centrifuged 
(1000 × g, 10 min and 4ºC). Afterwards, 200 µl of supernatant were 
mixed with 40 µl of HCl (0.6 M) and 160 µl of TBA dissolved in Tris 
and then the mixture was heated at 80ºC for 10 min. The 
absorbance of the resultant supernatant was obtained at 530 nm. 
 
  
Statistical analysis 
 
All   experiments   were   performed   in   triplicate   and   data   was 
statistically analyzed with the ANOVA and Tukey or Dunnett’s test 
or test t, using the Prism Software (5.0). 
 
 
RESULTS AND DISCUSSION 
 
It is well known that the cytotoxicity induced by 
compounds can be tested by different methods such as 
lactate dehydrogenase leakage, MTT, protein synthesis 
inhibition, kenacid blue, Janus Green and trypan blue 
assays. However, MTT assay are the most common 
employed for the detection of cytotoxicity or cell viability 
following exposure to toxic substances (Fotakis and 
Timbrell, 2006). 
 
 
MTT assay 
 
The AEMC was evaluated on mice fibroblast cell line 
(L929) in order to examine their cytotoxic effects on 
normal cells. Cytotoxicity of the AEMC on the growth of 
the L929 cell line is showed in Figure 1. Cell proliferation 
was analyzed 24 h after L929 cells had been cultured 
with the AEMC at 0.05, 0.1, 0.2, 0.4, 0.8, 1.6, 3.2, 6.4 and 
12.8 mg/ml in the final concentration using the MTT 
assay. The AEMC at concentrations of 0.05 to 12.8 
mg/ml did not show any cytotoxic effect in L929  cell  line. 
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Figure 2.  Body weight curves for male and female mice treated with AEMC or salina solution for 15 days. 
Each value represents the mean ± SD. 
 
 
 
Several studies have shown that results from toxicity 
studies such as the MTT test might be used to predict the 
possible toxicity of compounds for the animal (Ekwall et 
al., 1989; Roguet et al., 1993) and using in vitro and in 
vivo methods, it is usually possible to achieve toxic 
concentrations with even the most innocuous materials 
(Phillips, 1996). 
 
 
Acute toxicity study 
 
In the acute toxicity test, 5 g/kg of AEMC did not cause 
the death during a 14-day observation period. The rats 
did not show any sign of toxicity or change in behavioral 
changes or other physiological activities. A 5 g/kg dose 
was considered as the “Limit test”, as recommended by 
acute toxicity testing procedures. Therefore, 
administration of further higher doses was considered 
physiologically unsound and is not generally 
recommended (Araujo et al., 2008). 
The experiments in vivo showed that the administration 
of AEMC (5 g/kg, p. o.) after 15 days did not modify the 
profile of weight when test and control groups were 
compared (Figure 2). Besides, food and water 
consumption for the control group and for the treated 
group were kept within the means established for this 
animal species.  
There were no verified changes in the weight of the 
organs (Table 1), fourteen days after acute treatment with 
5 g/kg of AEMC. Only in the male rats were there 
significant differences in the relative weights of the livers, 
as shown. 
These data might be related either to some casual 
variabilities  in  the weight of the livers, unrelated  to the 
hepatic functions, or to some subclinical abnormalities 
which had determined a possible condition of hypertrophy 
or hyperplasia of the liver tissues. Therefore, further 
morphometric analyses are necessary in order to 
compare to the test and control groups and clarify the 
real nature of such results. 
 
 
Hematological analysis  
 
Results of the hematological studies are presented in 
Table 2. The data shows that leukocyte, erythrocytes, 
hemoglobin, mean corpuscular hemoglobin (MCH), 
hemoglobin, platelets, neutrophil, lymphocyte, monocyte, 
basophil and eosinophil levels for the control rats were 
not significantly different from those treated with AEMC 
during the period of study. Only the hematocrit, mean 
corpuscular volume (MCV) and mean corpuscular 
hemoglobin concentration (MCHC) levels were 
significantly different in the female treated groups, as 
compared to the control group (p < 0.05). 
 
 
Biochemical parameters 
 
Results of the biochemical parameters are presented in 
Table 3. The data shows that total, indirect and direct 
bilirubin (T Bil., I Bil., D Bil.), creatinine, gamma-glutamyl 
transferase (GGT), glucose, potassium, lactate 
dehydrogenase (LDH), urea and uric acid levels for the 
control rats were not significantly different from those 
treated with AEMC during the period of study. 
Nevertheless, the albumin, alkaline phosphatase, alanine 
amino   transferase   (ALT),  aspartate amino  transferase
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Table 1. Weigth of the organs after acute treatment with 5 g/kg of AEMC. 
 
Group 
Organ CF TF CM TM 
Left kidney 0.613 ± 0.033 0.660 ± 0.021 0.843 ± 0.033 0.806 ± 0.037 
RightKidney 0.615 ± 0.033 0.671 ± 0.023 0.873 ± 0.040 0.835 ± 0.051 
Stomach 1.897 ± 0.152 1.667 ± 0.041 2.417 ± 0.218 3.067 ± 0.327 
Heart 0.660 ± 0.026 0.685 ± 0.011 0.863 ± 0.157 0.930 ± 0.049 
Lung 1.385 ± 0.113 1.353 ± 0.126 1.515 ± 0.118 1.320 ± 0.046 
Liver 5.175 ± 0.175 5.173 ± 0.180 7.818 ± 0.165 6.522 ± 0.266** 
Brain 1.638 ± 0.056 1.673 ± 0.035 1.657 ± 0.045 1.712 ± 0.076 
 
CF (control female), TF (test female), CM (control male) and TM (test male). Data is expressed as mean ± S.D., n= 6. * Indicate 
statistical difference between the control and treated group (p < 0.05) and ** p < 0.01. 
 
 
 
Table 2. Results of the hematological studies after acute treatment with 5 g/kg of AEMC. 
 
Parameter Group 
CF TF CM TM 
Leukocyte (×103/mm3) 9.348 ± 0.5171 9.660 ± 0.7909 7.622 ± 0.6129 9.727 ± 1.3730 
Erythrocytes (×106/mm3) 7.868 ± 0.0518 7.890 ± 0.0920 7.318 ± 0.1982 7.103 ± 0.0954 
Hemoglobin (g/dl) 14.68 ± 0.1376 14.53 ± 0.1116 13.68 ± 0.3016 13.68 ± 0.2040 
Hematócrit (%) 42.80 ± 0.5526 41.38 ± 0.2344* 40.98 ± 0.7373 40.32 ± 0.6680 
MCV (fl) 54.40 ± 0.5972 52.48 ± 0.4061* 56.10 ± 1.0090 56.77 ± 0.6830 
CMH (pg) 18.67 ± 0.1282 18.43 ± 0.1054 18.73 ± 0.1764 19.25 ± 0.1875 
MCHC (g/dl) 34.32 ± 0.1922 35.12 ± 0.1046** 33.38 ± 0.4743 33.93 ± 0.0881 
Platelets (×106/mm3) 1221 ± 68.690 1136.0 ± 58.95 1252 ± 71.130 1152 ± 45.640 
Neutrophi l(%) 20.920 ± 1.641 23.980 ± 3.414 24.73 ± 2.6410 25.42 ± 5.0120 
Lymphocyte (%) 73.720 ± 1.782 70.370 ± 3.647 69.62 ± 2.3760 70.27 ± 5.1430 
Monocyte (%) 4.517 ± 0.6824 4.367 ± 0.4128 4.383 ± 0.5108 3.683 ± 0.4230 
Eosinophil (%) 0.850 ± 0.0763 1.283 ± 0.4206 1.267 ± 0.5566 0.633 ± 0.0760 
Basophil (%) 0.000 ± 0.0000 0.000 ± 0.0000 0.000 ± 0.0000 0.000 ± 0.0000 
 
CF (control female), TF (test female), CM (control male) and TM (test male). Data is expressed as mean ± S.D, n = 6.  
* Indicate statistical difference between the control and treated group (p < 0.05) and ** p < 0.01. 
 
 
 
(AST), globulin, sodium  and total protein levels in test 
groups were significantly lower than control group (p < 
0.05). 
 
 
Tissue analysis 
 
Pathological examination of the tissues on a gross basis 
indicated that there were no detectable abnormalities; 
either in weight or in appearance and no significant 
differences were grossly detected between control and 
experimental groups. Moreover, the organs of both 
groups were unremarkable and comparable to each sex.  
Microscopical analysis of the examined internal organs 
revealed that their architectural and cellular appearance 
were   comparatively   unremarkable in  both  groups  and 
sexes. Nevertheless, some pulmonary samples from both 
experimental and control groups revealed a picture of 
slight and focal atelectasy. According to Araújo et al. 
(2008), this morphological alteration might have been a 
result of some already expected changes in their blood 
pressure and respiratory rhythm, probably due to the 
conditions of continuous stress caused by experimental 
manipulation of the animals. Therefore, it seems 
absolutely clear that the focal morphological picture of 
atelectasy is not related to the AEMC oral administration. 
 
 
Oxidative damage 
 
Hepatocytes, which make up the majority of the liver 
structure, are very active in the metabolism of exogenous  
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Table 3. Results of the biochemical parameters after acute treatment with 5 g/kg of AEMC. 
 
Parameter 
Group 
CF TF CM TM 
Albumin (g/dL) 3.067 ± 0.033 2.90 ± 0.0365** 2.900 ± 0.0577 2.90 ± 0.0365 
Alkalinephosphatase (U/L) 85.67 ± 8.508 71.83 ± 7.387 187.8 ± 13.30 139.3 ± 7.451** 
ALT (U/L) 39.00 ± 2.840 32.67 ± 0.802 55.67 ± 1.978 46.50 ± 2.187* 
AST (U/L) 117.7 ± 1.626 91.83 ± 7.993* 120.3 ± 6.453 102.0 ± 4.008* 
IBil. (mg/dL) 0.000 ± 0.000 0.000 ± 0.000 0.000 ± 0.000 0.000 ± 0.000 
D Bil. (mg/dL) 0.010 ± 0.000 0.010 ± 0.000 0.010 ± 0.000 0.010 ± 0.000 
T Bil. (mg/dL) 0.010 ± 0.000 0.010 ± 0.000 0.010 ± 0.000 0.010 ± 0.000 
Creatinine (mg/dL) 0.490 ± 0.008 0.470 ± 0.009 0.475 ± 0.011 0.471 ± 0.013 
GGT (U/L) < 4.00 ± 0.000 < 4.00 ± 0.000 < 4.00 ± 0.000 < 4.00 ± 0.000 
Globulin (mg/dL) 3.333 ± 0.076 3.000 ± 0.082* 2.983 ± 0.075 2.867 ± 0.105 
Glucose (mg/dL) 78.00 ± 5.138 88.17 ± 6.369 97.50 ± 7.706 91.83 ± 6.478 
K+ (mmol/L) 4.600 ± 0.100 4.667 ± 0.092 4.883 ± 0.225 4.917 ± 0.070 
Na+ (mmol/L) 140.2 ± 0.307 139.5 ± 0.428 142.8 ± 0.401 140.2 ± 0.872* 
Total protein (g/dL) 6.400 ± 0.089 5.90 ± 0.0894** 5.883 ± 0.127 5.767 ± 0.117 
LDH (mg/dL) 94.83 ± 11.84 76.83 ± 6.560 113.0 ± 9.633 120.8 ± 15.70 
Urea (mg/dL) 36.17 ± 2.442 32.67 ± 3.007 35.33 ± 1.382 49.83 ± 5.082 
Uric acid (mg/dL) 1.100 ± 0.000 1.016 ± 0.183 1.150 ± 0.152 0.9333 ± 0.092 
 
CF (control female), TF (test female), CM (control male) and TM (test male). Data is expressed as mean ± S.D, n = 6.  
* Indicate statistical difference between the control and treated group (p < 0.05) and ** p < 0.01. 
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Figure 3. Oxidative damage after acute treatment with 5 g/kg of M. citrifolia. CM 
(control male), TM (test male), CF (control female) and TF (test female). Data 
are expressed as mean ± S.D., n = 6. There is no statistical difference between 
the control and treated group. (test t: control male x test male and control 
female x test female). 
 
 
 
chemicals and this is one of the major reasons why the 
liver is a target for toxic substances (Timbrell, 2001). 
During the detoxification of xenobiotics, reactive oxygen 
species (ROS) are generated which cause oxidative 
stress (Kohen and Nyska, 2002).  
A primary measure of oxidative damage in liver is lipid 
peroxidation, where TBA is measured as and the index of 
lipid peroxidation. Thus, after pre treatment with AEMC, 
the liver was evaluated and the decrease of the damage 
caused by AEMC was observed, as shown in Figure 3.  
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These results indicate that there was no induction of 
repair mechanisms. 
 
 
Conclusion 
 
In conclusion, this investigation demonstrates that at 
doses consumed in the traditional medicine (620 mg 
2x/day, 1000 mg/day or 30 ml/day), the AEMC may be 
considered as safe, as it did not cause either any lethality 
or changes of the general behavior in the acute toxicity 
and cytotoxicity studies in rodents. However, the results 
reported here do not imply that AEMC would have no 
toxic effects in humans, but simply constitute a baseline 
data for further studies. Studies of this type are needed 
before a phytotherapeutic agent can be generally 
recommended for use. 
 
 
Abbreviations 
 
AEMC, aqueous extract of Morinda citrifolia; MTT, 3-(4,5-
dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide; 
DMEM, Dulbecco's Modified Eagle's Medium; PBS, 
phosphate buffer saline; SDS, sodium dodecyl sulfate; 
EDTA, Ethylenediaminetetracetic acid; AST, aspartate 
amino transferase; ALT, alanine amino transferase; 
GGT, Gamma-glutamyltransferase; TBil, total billirubin, 
DBil, direct bilirubin; ALP, alkaline phosphatase; TBARS, 
thiobarbituric acid reactive substances; TBA, 
thiobarbituric acid; MDA, malondialdehyde; TCA–BHT, 
trichloro acetic acid – butyl hydroxyl toluene; MCH, mean 
corpuscular hemoglobin; MCV, mean corpuscular 
volume; MCHC, mean corpuscular Hemoglobin 
concentration; LDH, lactate dehydrogenase; ROS, 
reactive oxygen species. 
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